TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
|
|
|
||||
1. Identity of the issuer or the underlying issuer |
PureTech Health plc |
||||
2 Reason for the notification (please tick the appropriate box or boxes): |
|||||
An acquisition or disposal of voting rights |
✓ |
||||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
|
||||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments |
|
||||
An event changing the breakdown of voting rights |
|
||||
Other (please specify): |
|
|
|||
3. Full name of person(s) subject to the |
Zohar LLC |
||||
4. Full name of shareholder(s) |
|
||||
5. Date of the transaction and date on |
20 May 2016 |
||||
6. Date on which issuer notified: |
20 May 2016 |
||||
7. Threshold(s) that is/are crossed or |
5%, 4% |
||||
8. Notified details: |
||||||||||||||||
A: Voting rights attached to shares viii, ix |
||||||||||||||||
Class/type of
|
Situation previous |
Resulting situation after the triggering transaction |
||||||||||||||
Number |
Number |
Number |
Number of voting |
% of voting rights x |
||||||||||||
Direct |
Direct xi |
Indirect xii |
Direct |
Indirect |
||||||||||||
Ordinary Shares |
11,890,157 |
11,890,157 |
7,134,094 |
7,134,094 |
- |
3.01 |
- |
|||||||||
GB00BY2Z0H74 |
||||||||||||||||
|
||||||||||||||||
B: Qualifying Financial Instruments |
||||||||||||||||
Resulting situation after the triggering transaction |
||||||||||||||||
Type of financial |
Expiration |
Exercise/ |
Number of voting |
% of voting |
||||||||||||
|
|
|
|
|
||||||||||||
|
||||||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi |
||||||||||||||||
Resulting situation after the triggering transaction |
||||||||||||||||
Type of financial |
Exercise price |
Expiration date xvii |
Exercise/ |
Number of voting rights instrument refers to
|
% of voting rights xix, xx
|
|||||||||||
|
|
|
|
|
Nominal |
Delta |
||||||||||
|
|
|||||||||||||||
|
||||||||||||||||
Total (A+B+C) |
||||||||||||||||
Number of voting rights |
Percentage of voting rights |
|||||||||||||||
|
|
|||||||||||||||
9. Chain of controlled undertakings through which the voting rights and/or the |
||
|
||
|
||
Proxy Voting: |
||
10. Name of the proxy holder: |
|
|
11. Number of voting rights proxy holder will cease |
|
|
12. Date on which proxy holder will cease to hold |
|
|
|
||
|
The triggering transaction comprises the transfer from Zohar LLC of: (i) 2,378,032 ordinary shares in the issuer to the Zohar Family Trust I, a US-established trust of which Daphne Zohar is a beneficiary and trustee; and (ii) 2,378,031 ordinary shares in the issuer to the Zohar Family Trust II, a US-established trust of which Daphne Zohar is a beneficiary (in the event of her spouse's death) and trustee, in each case for nil consideration. The Company was informed that these transfers are for estate planning purposes.
There has been no change in the total number of voting rights directly or indirectly held by Daphne Zohar. |
|
14. Contact name: |
Stephen M. Muniz |
|
15. Contact telephone number: |
+1 617.456.0042 |
|